Stem cell therapy: FDA regulatory science aims to facilitate development of safe and effective regenerative medicine products

FDA's official blog brought to you from FDA's senior leadership and staff stationed at home and abroad - sharing news, background, announcements and other information about the work done at the FDA on behalf of the American public.

Steve Bauer, Ph.D., chief of the Cellular and Tissues Therapy Branch, Division of Cellular and Gene Therapies, in the Office of Cellular, Tissue and Gene Therapy at CBER.

By: Steve Bauer, Ph.D.

Food & Drug Administration (FDA)

News Well, Blog, Food & Drug Administration (FDA)

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/XnSq5K